About 100 reports

Congestive Heart Failure (Heart Failure) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...

  • Cardiovascular Disease
  • Heart Failure
  • World
  • Alcohol Excessive Use

Heart Failure POC & LOC Devices market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Heart Failure POC & LOC Devices Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Heart Failure POC & LOC Devices types,...

  • Heart Failure
  • World

Congestive Heart Failure (Heart Failure) (Cardiovascular) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure - Drugs In Development, 2021, provides an overview of the Congestive Heart Failure (Cardiovascular) pipeline landscape. Heart...

  • Cardiovascular Disease
  • Heart Failure
  • World
  • Alcohol Excessive Use

Abstract: - Global Heart Failure Drugs Market to Reach $11.3 Billion by 2027 - Amid the COVID-19 crisis, the global market for Heart Failure Drugs estimated at US$5 Billion in the year 2020, is projected to reach a revised size of US$11.3 Billion by 2027, growing at a CAGR of 12.4% over the period 2020-2027. -...

  • Heart Failure
  • World
  • China
  • United States
  • Canada

Abstract: - Global Acute Heart Failure (AHF) Therapeutics Market to Reach $1.5 Billion by 2027 - Amid the COVID-19 crisis, the global market for Acute Heart Failure (AHF) Therapeutics estimated at US$372.9 Million in the year 2020, is projected to reach a revised size of US$1.5 Billion by 2027, growing at a CAGR of...

  • Therapy
  • Heart Failure
  • World
  • China
  • United States

Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure - Pipeline Review, H2 2020, provides an overview of the Congestive Heart Failure (Cardiovascular) pipeline landscape. Heart...

  • Cardiovascular Disease
  • Heart Failure
  • World
  • Alcohol Excessive Use

Global Heart Failure Drugs Market 2021-2025 The analyst has been monitoring the heart failure drugs market and it is poised to grow by $ 2.69 bn during 2021-2025, progressing at a CAGR of 7.75% during the forecast period. Our report on the heart failure drugs market provides a holistic analysis, market size and forecast,...

  • Heart Failure
  • World

The South and Central America non-invasive cardiac output monitoring device market is expected to reach US$ 22,733.02 thousand by 2027 from US$ 16,828.46 thousand in 2020; it is estimated to grow at a CAGR of 4.4% from 2020 to 2027. The growth of the market is attributed to a few key driving factors such as increase in prevalence of cardiovascular...

  • Cardiovascular Disease
  • Hospital
  • Heart Failure
  • Central America
  • Smoking Prevalence
  • Health Expenditure

The North America non-invasive cardiac output monitoring device market is expected to reach US$ 129,912.44 thousand by 2027 from US$ 95,471.09 thousand in 2020; it is expected to grow at a CAGR of 5.1% from 2020 to 2027. The growth of the market is attributed to a few key driving factors such as increase in prevalence of cardiovascular diseases...

  • Cardiovascular Disease
  • Hospital
  • Heart Failure
  • World
  • North America
  • United States
  • Health Expenditure
  • Mortality Rate

The Middle East and Africa non-invasive cardiac output monitoring device market is expected to reach US$ 10,886.70 thousand by 2027 from US$ 8,449.53 thousand in 2020; it is expected to grow at a CAGR of 3.7% from 2020 to 2027. The growth of the market is attributed to a few key driving factors such as rise in geriatric population, and development...

  • Cardiovascular Disease
  • Hospital
  • Heart Failure
  • Middle East
  • Africa
  • Smoking Prevalence
  • Health Expenditure

The Asia Pacific non-invasive cardiac output monitoring device market is expected to reach US$ 72,964.07 thousand by 2027 from US$ 50,179.39 thousand in 2020; it is expected to grow at a CAGR of 5.5% from 2020 to 2027. The growth of the market is attributed to a few key driving factors such as increase in prevalence of cardiovascular diseases...

  • Cardiovascular Disease
  • Hospital
  • Heart Failure
  • APAC
  • Smoking Prevalence
  • Health Expenditure

Acute Heart Failure (Cardiovascular) - Drugs in Development, 2021 Summary Acute Heart Failure (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Acute Heart Failure pipeline landscape. The report provides comprehensive information on the therapeutics under development...

  • Heart Failure
  • World

Systolic Heart Failure (Cardiovascular) - Drugs in Development, 2021 Summary Systolic Heart Failure (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Systolic Heart Failure pipeline landscape. The report provides comprehensive information on the therapeutics under development...

  • Heart Failure
  • World

Diastolic Heart Failure (Cardiovascular) - Drugs in Development, 2021 Summary Diastolic Heart Failure (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Diastolic Heart Failure pipeline landscape. The report provides comprehensive information on the therapeutics under...

  • Heart Failure
  • World

The Europe non-invasive cardiac output monitoring device market is expected to reach US$ 94,406.57 thousand by 2027 from US$ 68,443.56 thousand in 2020; it is expected to grow at a CAGR of 4.7% from 2020 to 2027. The growth of the market is attributed to a few key driving factors such as rise in geriatric population, and development and launch...

  • Cardiovascular Disease
  • Hospital
  • Heart Failure
  • Europe
  • Health Expenditure
  • Cause-Specific Mortality Rate

The heart conditions are considered advanced or end-stage heart failure when conventional heart therapies and management strategies no longer work. The reduced ability of the heart to pump blood and maintain normal bodily function leads to heart failure. Heart transplantation is currently the preferred treatment for...

  • Cardiovascular Devices
  • Heart Failure
  • United States

Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure - Pipeline Review, H1 2020, provides an overview of the Congestive Heart Failure (Cardiovascular) pipeline landscape. Heart...

  • Cardiovascular Disease
  • Heart Failure
  • World
  • Alcohol Excessive Use

Ventricular Assist Device Market Size, Share & Trends Analysis Report By Product, By Type Of Flow (Pulsatile Flow, Continuous Flow), By Application, By Design, By Region, And Segment Forecasts, 2021 - 2028 Ventricular Assist Device Market Growth & Trends The global ventricular assist device...

  • Cardiovascular Disease
  • Heart Failure
  • World
  • Germany
  • United States
  • Hospital Expenditure

The non-invasive cardiac output monitoring device market is expected to reach US$ 3,30,902.81 thousand by 2027 from US$ 2,26,049.76 thousand in 2019; it is expected to grow at a CAGR of 5.0% from 2020 to 2027. The growth of the non-invasive cardiac output monitoring device market is mainly attributed to increase in prevalence of cardiovascular...

  • Cardiovascular Disease
  • Hospital
  • Heart Failure
  • World
  • APAC
  • Europe
  • North America
  • Middle East
  • Africa
  • Smoking Prevalence
  • Cause-Specific Mortality Rate

Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary According to the recently published report ’Histone Deacetylase 4 - Drugs In Development, 2022’; Histone Deacetylase...

  • Cancer
  • Therapy
  • Drug Development
  • Gene Therapy
  • Heart Failure
  • World
  • Stem Cell Transplantation

In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global IV and Oral Iron Drugs Market Report The global IV and oral iron drugs market by revenue is expected to grow at a CAGR of 11.6% during the period 2021–2026. The global IV and oral iron drugs market is expected to grow due to the prevalence...

  • Healthcare
  • Pharmaceutical
  • Therapy
  • Endocrine Disease
  • Nutrition
  • Blood Disease
  • E-Commerce
  • Heart Failure
  • World
  • Anemia Prevalence
  • Health Expenditure

Global LVAD Market 2021-2025 The analyst has been monitoring the LVAD market and it is poised to grow by $ 962.42 mn during 2021-2025, progressing at a CAGR of over 12% during the forecast period. Our report on LVAD market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as...

  • Heart Failure
  • World

Histone Deacetylase 4 - Pipeline Review, H2 2020 Summary Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) - Histone deacetylase 4 (HDAC4) is a protein encoded by the HDAC4 gene. It is responsible for the deacetylation of lysine residues on the N-terminal part of the core histones....

  • Therapy
  • Drug Development
  • Heart Failure
  • Gene Therapy
  • World
  • Mortality Rate
  • Stem Cell Transplantation

Global Ventricular Assist Devices Market 2021-2025 The analyst has been monitoring the ventricular assist devices market and it is poised to grow by $ 4.05 bn during 2021-2025, progressing at a CAGR of 21.46% during the forecast period. Our report on the ventricular assist devices market provides a holistic analysis, market...

  • Heart Failure
  • Marketing Research
  • World

Global Extracorporeal Membrane Oxygenation Machines Market 2021-2025 The analyst has been monitoring the extracorporeal membrane oxygenation machines market and it is poised to grow by $ 239.83 mn during 2021-2025, progressing at a CAGR of 10.27% during the forecast period. Our report on the extracorporeal membrane oxygenation...

  • Heart Failure
  • Marketing Research
  • World

The global prevalence of CKD is estimated to be about 9% to 10%.Chronic Kidney Disease (CKD) is associated with poor outcomes, mainly due to the high burden of comorbidity. Along with rising aging population, increasing number of CKD patients are suffering from comorbidities such as hypertension, diabetes, heart failure, cancer, and...

  • Chronic Disease
  • Renal Disease
  • Managed Care
  • Antidiabetics
  • Heart Failure
  • Hypertension
  • World

Cytochrome P450 11B2 Mitochondrial - Pipeline Review, H2 2019 Summary Cytochrome P450 11B2 Mitochondrial (Aldosterone Synthase or Cytochrome P450Aldo or Cytochrome P450C18 or Steroid 18 Hydroxylase or CYP11B2 or EC 1.14.15.4 or EC 1.14.15.5) - Aldosterone synthase is a steroid hydroxylase cytochrome...

  • Therapy
  • Cardiovascular Disease
  • Heart Failure
  • Pharmaceutical
  • World
  • Prescription Drug Sales
  • Pharmaceutical Registrations

Global Ventricular Assist Devices Market: About this market This ventricular assist devices market analysis considers sales from left and right ventricular assist devices and bi-ventricular assist devices products. Our study also finds the sales of ventricular assist devices in Asia, Europe, North America, and ROW. In...

  • Heart Failure
  • Cardiovascular Disease
  • World

Global Extracorporeal Membrane Oxygenation Machines Market: About this market This extracorporeal membrane oxygenation machines market analysis considers sales from veno-venous and arterio-venous; and veno-arterial modalities. Our study also finds the sales of extracorporeal membrane oxygenation machines in Asia, Europe,...

  • Cardiovascular Disease
  • Heart Failure
  • World

The global ventricular assist devices market reached a value of US$ 1.56 Billion in 2021. Looking forward, the analyst expects the market to reach US$ 2.80 Billion by 2027, exhibiting a CAGR of 10.09% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect...

  • Healthcare
  • Cardiovascular Disease
  • Ambulatory Care
  • Infection Control
  • Medical Benefit
  • Clinical Trial
  • Heart Failure
  • Health Care Provider
  • Heart Transplant
  • Hospital
  • World
  • Mortality Rate